P27Kip1 serine 10 phosphorylation determines its metabolism and interaction with cyclin-dependent kinases

Cell Cycle

Volumn 13, Issue 23, 2014, Pages 3768-3782

  Bencivenga, Debora ^a   Tramontano, Annunziata ^a   Borgia, Alessia ^a   Negri, Aide ^b   Caldarelli, Ilaria ^a   Oliva, Adriana ^a   Perrotta, Silverio ^a   Ragione, Fulvio Della ^a   Borriello, Adriana ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Cyclin depedent kinases regulation; P27Kip1; P27Kip1 metabolism; P27Kip1 modifications

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR 1B; PHOSPHOSERINE; THREONINE; CDKN1B PROTEIN, HUMAN; PROTEIN BINDING; SERINE;

ARTICLE; CELL MOTION; ELECTROPHORESIS; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MALIGNANT TRANSFORMATION; MITOSIS; PROTEIN FUNCTION; PROTEIN METABOLISM; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; MESENCHYMAL STROMA CELL; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY;

CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLIN-DEPENDENT KINASES; HUMANS; MESENCHYMAL STROMAL CELLS; PHOSPHORYLATION; PROTEIN BINDING; SERINE;

EID: 84920597046     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/15384101.2014.965999     Document Type: Article

References (63)

1. Slingerland J, Pagano M. Regulation of the cdk inhibitor p27 and its deregulation in cancer. J Cell Physiol 2000; 183:10-7; PMID:10699961; http:// dx.doi.org/10.1002/(SICI)1097-4652(200004)183:1 <10::AID-JCP2 >3.0.CO;2-I
2. Chu IM, Hengst L, Slingerland JM. The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy. Nat Rev Cancer 2008; 8:253-67; PMID:18354415; http://dx.doi.org/ 10.1038/nrc2347
3. Ciarallo S, Subramaniam V, Hung W, Lee JH, Kotchetkov R, Sandhu C, Milic A, Slingerland JM. Altered p27Kip1 phosphorylation, localization, and function in human epithelial cells resistant to transforming growth factor b-mediated G1 arrest. Mol Cell Biol 2002; 22:2993-3002; PMID:11940657; http://dx.doi.org/ 10.1128/MCB.22.9.2993-3002.2002
4. James MK, Ray A, Leznova D, Blain SW. Differential modification of p27Kip1 controls its cyclin D cdk4 inhibitory activity. Mol Cell Biol 2008; 28:498-510; PMID:17908796; http://dx.doi.org/10.1128/MCB. 02171-06
5. Larrea MD, Liang J, Da Silva T, Hong F, Shao SH, Han K, Dumont D, Slingerland JM. Phosphorylation of p27Kip1 regulates assembly and activation of cyclin D1-Cdk4. Mol Cell Biol 2008; 28:6462-72; PMID:18710949; http://dx.doi.org/10.1128/MCB. 02300-07
6. Besson A, Gurian-West M, Chen X, Kelly-Spratt KS, Kemp CJ, Roberts JM. A pathway in quiescent cells that controls p27Kip1 stability, subcellular localization, and tumor suppression. Genes Dev 2006; 20:47-64; PMID:16391232; http://dx.doi.org/10.1101/gad. 1384406
7. Nguyen L, Besson A, Heng JI, Schuurmans C, Teboul L, Parras C, Philpott A, Roberts JM, Guillemot F. p27kip1 independently promotes neuronal differentiation and migration in the cerebral cortex. Genes Dev 2006; 20:1511-24; PMID:16705040; http://dx.doi. org/10.1101/gad.377106
8. McAllister SS, Becker-Hapak M, Pintucci G, Pagano M, Dowdy SF. Novel p27kip1 C-terminal scatter domain mediates Rac dependent cell migration independent of cell cycle arrest functions. Mol Cell Biol 2003; 23:216-28; PMID:12482975; http://dx.doi.org/ 10.1128/MCB.23.1.216-228.2003
9. Besson A, Gurian-West M, Schmidt A, Hall A, Roberts JM. p27Kip1 modulates cell migration through the regulation of RhoA activation. Genes Dev 2004; 15:862-76; http://dx.doi.org/10.1101/gad.1185504
10. Larrea MD, Hong F, Wander SA, da Silva TG, Helfman D, Lannigan D, Smith JA, Slingerland JM. RSK1 drives p27Kip1 phosphorylation at T198 to promote RhoA inhibition and increase cell motility. Proc Natl Acad Sci USA 2009; 106:9268-73; PMID:19470470; http://dx.doi.org/10.1073/pnas.0805057106
11. Mohanty AR, Kan Q, Srivastava S, Uranbileg B, Ara-kawa-Takeuchi S, Fujita N, Okayama H. Successive phosphorylation of p27(KIP1) protein at serine-10 and C terminus crucially controls its potency to inactivate Cdk2. J Biol Chem 2012; 287:21757-64; PMID: 22584582; http://dx.doi.org/10.1074/jbc.M112. 346254
12. Uranbileg B, Yamamoto H, Park JH, Mohanty AR, Arakawa-Takeuchi S, Jinno S, Okayama H. Cdc6 protein activates p27KIP1-bound Cdk2 protein only after the bound p27 protein undergoes C-terminal phosphorylation. J Biol Chem 2012; 287:6275-83; PMID:22223646; http://dx.doi.org/10.1074/jbc. M111.318295
13. Kajihara R, Fukushige S, Shioda N, Tanabe K, Fukunaga K, Inui S. CaMKII phosphorylates serine 10 of p27 and confers apoptosis resistance to HeLa cells. Biochem Biophys Res Commun 2010; 401:350-5; PMID:20851109; http://dx.doi.org/10.1016/j.bbrc. 2010.09.051
14. Pierantoni GM, Esposito F, Tornincasa M, Rinaldo C, Viglietto G, Soddu S, Fusco A. Homeodomain-interacting protein kinase-2 stabilizes p27(kip1) by its phosphorylation at serine 10 and contributes to cell motility. J Biol Chem 2011; 286:29005-13; PMID:21715331; http://dx.doi.org/10.1074/jbc. M111.230854
15. Chopra S, Fernandez De Mattos S, Lam EW, Mann DJ. Jab1 co-activation of c-Jun is abrogated by the serine 10-phosphorylated form of p27Kip1. J Biol Chem 2002; 277:32413-16; PMID:12119282; http://dx.doi. org/10.1074/jbc.C200311200
16. Lacy ER, Filippov I, Lewis WS, Otieno S, Xiao L, Weiss S, Hengst L, Kriwacki RW. p27 binds cyclin-CDK complexes through a sequential mechanism involving binding-induced protein folding. Nat Struct Mol Biol 2004; 11:358-64; PMID:15024385; http:// dx.doi.org/10.1038/nsmb746
17. Lacy ER, Wang Y, Post J, Nourse A, Webb W, Mapelli M, Musacchio A, Siuzdak G, Kriwacki RW. Molecular basis for the specificity of p27 toward cyclin dependent kinases that regulate cell division. J Mol Biol 2005; 349:764-73; PMID:15890360; http://dx.doi.org/ 10.1016/j.jmb.2005.04.019
18. Sivakolundu SG, Bashford D, Kriwacki RW. Disordered p27Kip1 exhibits intrinsic structure resembling the Cdk2Cyclin A-bound conformation. J Mol Biol 2005; 353:1118-28; PMID:16214166; http://dx.doi. org/10.1016/j.jmb.2005.08.074
19. Vlach J, Hennecke S, Amati B. Phosphorylation-dependent degradation of the cyclin dependent kinase inhibitor p27. EMBO J 1997; 16:5334-44; PMID:9311993; http://dx.doi.org/10.1093/emboj/16.17.5334
20. Montagnoli A, Fiore F, Eytan E, Carrano AC, Draetta GF, Hershko A, Pagano M. Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation. Genes Dev 1995; 3:1181-89.
21. Carrano AC, Eytan E, Hershko A, Pagano M. SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat Cell Biol 1999; 1:193-9; PMID:10559916; http://dx.doi.org/10.1038/12013
22. Pagano M, Tam SW, Theodoras AM, Beer-Romero P, Del Sal G, Chau V, Yew PR, Draetta GF, Rolfe M. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science 1995; 269:682-5; PMID:7624798; http://dx.doi.org/10.1126/science.7624798
23. Ganoth D, Bornstein G, Ko TK, Larsen B, Tyers M, Pagano M, Hershko A. The cell-cycle regulatory protein Cks1 is required for SCF(Skp2)-mediated ubiquitinylation of p27. Nat Cell Biol 2001; 3:321-4; PMID:11231585; http://dx.doi.org/10.1038/ 35060126
24. Kamura T, Hara T, Matsumoto M, Ishida N, Okumura F, Hatakeyama S, Yoshida M, Nakayama K, Nakayama KI. Cytoplasmic ubiquitin ligase KPC regulates proteolysis of p27(Kip1) at G1 phase. Nat Cell Biol 2004; 61:229-35.
25. Hara T, Kamura T, Kotoshiba S, Takahashi H, Fujiwara K, Onoyama I, Shirakawa M, Mizushima N, Nakayama KI. Role of the UBL-UBA protein KPC2 in degradation of p27 at G1 phase of the cell cycle. Mol Cell Biol 2005; 25:9292-9303; PMID:16227581; http://dx.doi.org/10.1128/MCB. 25.21.9292-9303.2005
26. Smitherman M, Lee K, Swanger J, Kapur R, Clurman BE. Characterization and targeted disruption of murine Nup50, a p27(Kip1)-interacting component of the nuclear pore complex. Mol Cell Biol 2000; 20:5631-42; PMID:10891500; http://dx.doi.org/10.1128/ MCB.20.15.5631-5642.2000
27. Muller D, Thieke K, Burgin A, Dickmanns A, Eilers M. Cyclin E-mediated elimination of p27 requires its interaction with the nuclear pore-associated protein mNPAP60. EMBO J 2000; 19:2168-80; PMID:10811608; http://dx.doi.org/10.1093/emboj/ 19.10.2168
28. Liang J, Zubovitz J, Petrocelli T, Kotchetkov R, Connor MK, Han K, Lee JH, Ciarallo S, Catzavelos C, Beniston R, Franssen E, Slingerland JM. PKBAkt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest. Nat Med 2002; 8:1153-60; PMID:12244302; http://dx.doi.org/ 10.1038/nm761
29. Shin 1, Yakes FM, Rojo F, Shin NY, Bakin AV, Baselga J, Arteaga CL. PKBAkt mediates cell-cycle progression by phosphorylation of p27Kip1 at threonine 157 and modulation of its cellular localization. Nat Med 2002; 8:1145-52; PMID:12244301; http://dx.doi.org/ 10.1038/nm759
30. Fujita 1, Sato S, Katayama K, Tsuruo T. Akt-dependent phosphorylation of p27Kip1 promotes binding to 14-3-3 and cytoplasmic localization. J Biol Chem 2002; 277:28706-13; PMID:12042314; http://dx.doi. org/10.1074/jbc.M203668200
31. Liang J, Shao SH, Xu ZX, Hennessy B, Ding Z, Larrea M, Kondo S, Dumont DJ, Gutterman JU, Walker CL, Slingerland JM, Mills GB. The energy sensing LKB1-AMPK pathway regulates p27(kip1) phosphorylation mediating the decision to enter autophagy or apoptosis. Nat Cell Biol 2007; 9:218-24; PMID:17237771; http://dx.doi.org/10.1038/ncb1537
32. Fujita N, Sato S, Tsuruo T. Phosphorylation of p27Kip1 at threonine 198 by p90 localization. J Biol Chem 2003; 278:49254-60; PMID:14504289; http:// dx.doi.org/10.1074/jbc.M306614200
33. Hong F, Larrea MD, Doughty C, Kwiatkowski DJ, Squillace R, Slingerland JM. mTOR-raptor binds and activates SGK1 to regulate p27 phosphorylation. Mol Cell 2008; 30:701-11; PMID:18570873; http://dx.doi. org/10.1016/j.molcel.2008.04.027
34. Morishita D, Katayama R, Sekimizu K, Tsuruo T, Fujita N. Pim kinases promote cell cycle progression by phosphorylating and down-regulating p27Kip1 at the transcriptional and posttranscriptional levels. Cancer Res 2008; 68:5076-85; PMID:18593906; http://dx. doi.org/10.1158/0008-5472.CAN-08-0634
35. Chu I, Sun J, Arnaout A, Kahn H, Hanna W, Narod S, Sun P, Tan CK, Hengst L, Slingerland J. p27 phosphorylation by Src regulates inhibition of cyclin ECdk2. Cell 2007; 128:281-94; PMID:17254967; http://dx.doi.org/10.1016/j.cell.2006.11.049
36. Grimmler M, Wang Y, Mund T, Cilensek Z, Keidel EM, Waddell MB, Jakel H, Kullmann M, Kriwacki RW, Hengst L. Cdk-inhibitory activity and stability of p27Kip1 are directly regulated by oncogenic tyrosine kinases. Cell 2007; 128:269-80; PMID:17254966; http://dx.doi.org/10.1016/j.cell.2006.11.047
37. Kardinal C, Dangers M, Kardinal A, Koch A, Brandt DT, Tamura T, Welte K. Tyrosine phosphorylation modulates binding preference to cyclin-dependent kinases and subcellular localization of p27Kip1 in the acute promyelocytic leukemia cell line NB4. Blood 2006; 107:1133-40; PMID:16195327; http://dx.doi. org/10.1182/blood-2005-05-1771
38. Jakel H, Weinl C, Hengst L. Phosphorylation of p27Kip1 by JAK2 directly links cytokine receptor signaling to cell cycle control. Oncogene 2011; 30:3502-12; http://dx.doi.org/10.1038/onc.2011.68
39. Jakel H, Peschel I, Kunze C, Weinl C, Hengst L. Regulation of p27 (Kip1) by mitogen-induced tyrosine phosphorylation. Cell Cycle 2012; 11:1910-7; http:// dx.doi.org/10.4161/cc.19957
40. Ray A, James MK, Larochelle S, Fisher RP, Blain SW. p27Kip1 inhibits cyclin D-cyclin-dependent kinase 4 by two independent modes. Mol Cell Biol 2009; 29:986-99; PMID:19075005; http://dx.doi.org/ 10.1128/MCB.00898-08
41. Rodier G, Montagnoli A, Di Marcotullio L, Coulombe P, Draetta GF, Pagano M, Meloche S. p27 cytoplasmic localization is regulated by phosphorylation on Ser10 and is not a prerequisite for its proteolysis. EMBO J 2001; 20:6672-82; PMID:11726503; http://dx.doi. org/10.1093/emboj/20.23.6672
42. Boehm M, Yoshimoto T, Crook MF, Nallamshetty S, True A, Nabel GJ, Nabel EG. A growth factor-dependent nuclear kinase phosphorylates p27Kip1 and regulates cell cycle progression. EMBO J 2002; 21:3390-401; PMID:12093740; http://dx.doi.org/10.1093/ emboj/cdf343
43. Ishida N, Hara T, Kamura T, Yoshida M, Nakayama K, Nakayama KI. Phosphorylation of p27Kip1 on serine 10 is required for its binding to CRM1 and nuclear export. J Biol Chem 2002; 277:14355-8; PMID:11889117; http://dx.doi.org/10.1074/jbc. C100762200
44. Ishida N, Hara T, Kamura T, Yoshida M, Nakayama K, Nakayama KI. Phosphorylation at serine 10, a major phosphorylation site of p27Kip1, increases its protein stability. J Biol Chem 2000; 275:25146-54; PMID:10831586; http://dx.doi.org/10.1074/jbc. M001144200
45. Kotake Y, Nakayama K, Ishida N, Nakayama KI. Role of serine 10 phosphorylation in p27 stabilization revealed by analysis of p27 knock-in mice harboring a serine 10 mutation. J Biol Chem 2005; 280:1095-102; PMID:15528185; http://dx.doi.org/10.1074/jbc. M406117200
46. Borriello A, Cucciolla V, Criscuolo M, Indaco S, Oliva A, Giovane A, Bencivenga D, Iolascon A, Zappia V, Della Ragione F. Retinoic acid induces p27Kip1 nuclear accumulation by modulating its phosphorylation. Cancer Res 2006; 66:4240-8; PMID:16618747; http://dx.doi.org/10.1158/0008-5472.CAN-05-2759
47. Borriello A, Cucciolla V, Criscuolo M, Indaco S, Oliva A, Giovane A, Bencivenga D, Iolascon A, Zappia V, Della Ragione F. p27Kip1 accumulation is associated with retinoic-induced neuroblastoma differentiation: evidence of a decreased proteasome-dependent degradation. Oncogene 2000; 19:51-60; PMID:10644979; http://dx.doi.org/10.1038/sj.onc.1203231
48. Malek NP, Sundberg H, McGrew S, Nakayama K, Kyriakides TR, Roberts JM. A mouse knock-in model exposes sequential proteolytic pathways that regulate p27Kip1 in G1 and S phase. Nature 2001; 413:323-26; PMID:11565035; http://dx.doi.org/10.1038/ 35095083
49. Nakayama K, Nagahama H, Minamishima YA, Miyake S, Ishida N, Hatakeyama S, Kitagawa M, Iemura S, Natsume T, Nakayama KI. Skp2-mediated degradation of p27 regulates progression into mitosis. Dev Cell 2004; 6:661-72; PMID:15130491; http://dx.doi.org/ 10.1016/S1534-5807(04)00131-5
50. Borriello A, Cucciolla V, Oliva A, Zappia V, Della Ragione F. p27Kip1 metabolism: a fascinating labyrinth. Cell Cycle 2007; 6:1053-61; PMID:17426451; http://dx.doi.org/10.4161/cc.6.9.4142
51. Borriello A, Bencivenga D, Criscuolo M, Caldarelli I, Cucciolla V, Tramontano A Borgia A, Spina A, Oliva A, Naviglio S, Della Ragione F. Targeting p27Kip1 protein: its relevance in the therapy of human cancer. Expert Opin Ther Targets. 2011; 15:677-93; PMID:21355788; http://dx.doi.org/10.1517/ 14728222.2011.561318
52. Schiappacassi M, Lovisa S, Lovat F, Fabris L, Colombatti A, Belletti B, Baldassarre G. Role of T198 Modification in the Regulation of p27Kip1 Protein Stability and Function PLoS One 2011; 6:e17673; PMID:21423803; http://dx.doi.org/10.1371/journal. pone.0017673
53. Berthet C, Aleem E, Coppola V, Tessarollo L, Kaldis P. Cdk2 knockout mice are viable. Curr Biol 2003; 13:1775-85; PMID:14561402; http://dx.doi.org/ 10.1016/j.cub.2003.09.024
54. Martín A, Odajima J, Hunt SL, Dubus P, Ortega S, Malumbres M, Barbacid M. Cdk2 is dispensable for cell cycle inhibition and tumor suppression mediated by p27(Kip1) and p21(Cip1). Cancer Cell 2005; 7:591-8; http://dx.doi.org/10.1016/j.ccr.2005.05.006
55. Barbacid M, Ortega S, Sotillo R, Odajima J, Martín A, Santamaría D, Dubus P, Malumbres M. Cell cycle and cancer: genetic analysis of the role of cyclin-dependent kinases. Cold Spring Harb Symp Quant Biol 2005; 70:233-40; PMID:16869759; http://dx.doi.org/ 10.1101/sqb.2005.70.005
56. Barrière C, Santamaría D, Cerqueira A, Galáan J, Martín A, Ortega S, Malumbres M, Dubus P, Barbacid M. Mice thrive without Cdk4 and Cdk2. Mol Oncol 2007; 1:72-83; http://dx.doi.org/10.1016/j. molonc.2007.03.001
57. Santamaría D, Barrièere C, Cerqueira A, Hunt S, Tardy C, Newton K, Cáaceres JF, Dubus P, Malumbres M, Barbacid M. Cdk1 is sufficient to drive the mammalian cell cycle. Nature 2007; 448:811-5; http://dx.doi.org/ 10.1038/nature06046
58. Zhang W, Bergamaschi D, Jin B, Lu X. Posttranslational modifications of p27kip1 determine its binding specificity to different cyclins and cyclin-dependent kinases in vivo. Blood 2005; 105:3691-8; PMID:15665120; http://dx.doi.org/10.1182/blood-2003-07-2558
59. Fagan-Solis KD, Pentecost BT, Gozgit JM, Bentley BA, Marconi SM, Otis CN, Anderton DL, Schneider SS, Arcaro KF. SKP2 overexpression is associated with increased serine 10 phosphorylation of p27 (pSer10p27) in triple-negative breast cancer. J Cell Physiol 2014; 229:1160-9; PMID:24443386; http:// dx.doi.org/10.1002/jcp.24545
60. Matsuda Y, Wakai T, Hirose Y, Osawa M, Fujimaki S, Kubota M. p27 Is a critical prognostic biomarker in non-alcoholic steatohepatitis-related hepatocellular carcinoma. Int J Mol Sci 2013; 14:23499-515; PMID:24351862; http://dx.doi.org/10.3390/ ijms141223499
61. Katagiri K, Ueda Y, Tomiyama T, Yasuda K, Toda Y, Ikehara S, Nakayama KI, Kinashi T. Deficiency of Rap1-binding protein RAPL causes lymphoproliferative disorders through mislocalization of p27kip1. Immunity 2011; 34:24-38; PMID:21194982; http:// dx.doi.org/10.1016/j.immuni.2010.12.010
62. Mohanty AR, Kan Q, Srivastava S, Uranbileg B, Ara-kawa-Takeuchi S, Fujita N, Okayama H. Successive phosphorylation of p27Kip1 at serine-10 and C-terminus crucially controls its potency to inactivate Cdk2. J Biol Chem 2012; 287:21757-64; PMID:22584582; http://dx.doi.org/10.1074/jbc.M112.346254
63. Borriello A, Caldarelli I, Basile MA, Bencivenga D, Tramontano A, Perrotta S, Della Ragione F, Oliva A. The tyrosine kinase inhibitor dasatinib induces a marked adipogenic differentiation of human multipotent mesenchymal stromal cells. PLoS One 2011; 6: e28555; PMID:22164306; http://dx.doi.org/10.1371/ journal.pone.0028555